Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions

for
Hematologic, Oncologic, Bone Marrow
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT07743476

Recruiting

EORTC Metastatic Breast Cancer Module Development

for
Metastatic Beast Cancer
Location: Toronto
Sponsor: University of Leeds

Sex: Female

Age: 18+

Code: NCT07806266

Recruiting

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

for
Thrombosis, Cancer, Thrombosis, Deep Vein,
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT07372716

Recruiting

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

for
Breast Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Female

Age: 18+

Code: NCT07029490

Recruiting

Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors

for
Advanced or Metastatic Solid Tumors
Location: Boston MA, Detroit MI, Los Angeles CA
Sponsor: Hanmi Pharmaceutical Company Limited

Sex: All

Age: 18+

Code: NCT06724016

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

for
Selected Types of Solid Tumor
Location: New York NY, Fairfax VA, Houston TX
Sponsor: Everest Medicines (Beijing) Co., Ltd.

Sex: All

Age: 18+

Code: NCT07095868

Phase 1, Phase 2, Recruiting

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for
Solid Tumours
Location: Pittsburgh PA, Sioux Falls SD, Fort Worth TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07160725

Phase 1, Phase 2, Recruiting

Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

for
Mastectomy; Lymphedema, Breast Cancer
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06574022

Recruiting

Community Enhanced Virtual Informed Consent

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07805083

Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for
Solid Tumor, Adult, Non-small Cell Lung Cancer, Melanoma
Location: New York NY, New Brunswick NJ, Morristown NJ,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 18+

Code: NCT04913285

Phase 1, Recruiting

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

for
Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT07018986

Recruiting

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New York NY, Durham NC, Cleveland OH,
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06859762

Phase 1, Recruiting

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT06917313

Phase 2, Recruiting

Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma

for
Follicular Lymphoma, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06108232

Phase 2, Recruiting

Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care

for
Breast Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT07690852

Recruiting

Partner4Exercise Study

for
Cancer
Location: Hamilton
Sponsor: McMaster University

Sex: All

Age: 60+

Code: NCT07408128

Phase 2, Phase 3, Recruiting

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT07179809

Recruiting

Evaluating the Communication Between Patients and Providers in Cancer Clinics

for
Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison

Sex: All

Age: 18+

Code: NCT06985953

Recruiting

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: New York NY, Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06518057

Phase 2, Recruiting

A Study of a Digital Program for Helping Young Adult Cancer Survivors Learn About Financial Issues Related to Healthcare

for
Cancer
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18 - 39

Code: NCT07780903

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial